Biblio
.
Double knockout CRISPR screen for cancer resistance to T cell cytotoxicity. J Hematol Oncol. 2022;15(1):172.
. Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells. Cell. 2019;178(5):1189-1204.e23.